CannaGlobal Wellness Inc. was built as a combination of CannaGlobal, Sansero Life Sciences and Rise Wellness to become a global psychedelics leader focused on psilocybin and other natural compounds designed to promote emotional, mental and physical wellness.

CannaGlobal Wellness will fuse Sansero's best-in-class science team and capabilities in the development of novel formulations and intellectual property in psilocybin-based treatments, Rise Wellness' delivery of industry-shaping immersive healing experiences, and CannaGlobal's worldwide network of natural wellness pioneers. The synergies created by this merger will enable the company to offer an extensive and scalable menu of wellness solutions in the short term, while also accelerating the development and commercialization of psilocybin-based neurotherapeutics.

Lorne Gertner, Co-founder of Tokyo Smoke, Cannasat Therapeutics and The Cronos Group, will serve as Chairman of the new entity and leverage his vast experience and extensive network in the global cannabis and wellness industries to promote its growth.

The company is in the process of raising up to C$3 million at a pre-money valuation of C$20 million.

Steve Sadoff
CEO

Irie Selkirk
Head of Rise Wellness

Dr. Darryl Hudson, Ph.D.
Chief Science Officer